Countries across Asia are increasingly turning to health technology assessment (HTA) to ensure healthcare decisions are guided by appropriate evidence. However, many still face challenges in institutionalizing HTA, including building technical expertise, applying economic evaluation in decision-maki

Dr. Teerawat Wiwatpanit is a biomedical scientist by training. His expertise includes early health technology assessment, innovation development, and biomedical engineering for disease modeling and drug testing. He is passionate about promoting an efficient innovation landscape and translating scientific discoveries into practical healthcare soluti

Asst. Prof. Dr. Wang Yi is a co-founder of Medical Innovation Development and Assessment Support (MIDAS). His research areas include early health technology assessment, traditional health technology assessment, population’s preference for health and healthcare, and economic evaluation/analysis using real-world data and observational data. He is als

This report was prepared by Panchanok Muenkaew and Lapad Pongcharoenyong from the Health Intervention and Technology Assessment Program Foundation (HITAP), and reviewed by Saudamini Dabak. We would like to extend our sincere appreciation to Mark Landry from the World Health Organization (WHO), Thail

This report summarizes the study visit of delegates from the National Health Insurance Authority (NHIA), Ghana to the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand between 28 October and 1 November 2024.   The report has been prepared by Dr. Brandon Chua and M

Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand Jomkwan Yothasamut1, Choenkwan Putchong1, Teera Sirisamutr1, Yot Teerawattananon1, Sripen Tantivess1,2* 1Health Intervention and Technology Assessment Program, Ministry of Public Health,

Kalipso Chakidou1*, Ryan Li1, Anthony J. Culyer2, Amanda Glassman3, Karen J. Hofman4, Yot Teerawattananon5 1Institute of Global Health Innovation, Imperial College London, London, UK 2Department of Economics & Related Studies and Centre for Health Economics, University of York, York, UK 3Ce

Abstract Background Despite a growing global commitment to universal health coverage, considerable vaccine coverage and uptake gaps persist in resource-constrained settings. One way of addressing the gaps is by ensuring product innovation is relevant and responsive to the needs of these contexts

Abstract Early health technology assessment (early HTA) is a useful tool in guiding the innovation development process in medical technology development. However, the application of early HTA is sub-optimal amongst research and development (R&D) communities due to several challenges. In this pa

Objectives Based on a real-world collaboration with innovators in applying early health economic modeling, we aimed to offer practical steps that health technology assessment (HTA) researchers and innovators can follow and promote the usage of early HTA among research and development (R&D) comm